Publications by authors named "Elena Sendra"

Pseudomonas aeruginosa is one of the most common nosocomial pathogens and part of the top emergent species associated with antimicrobial resistance that has become one of the greatest threat to public health in the twenty-first century. This bacterium is provided with a wide set of virulence factors that contribute to pathogenesis in acute and chronic infections. This review aims to summarize the impact of multidrug resistance on the virulence and fitness of P.

View Article and Find Full Text PDF

Purpose: To design a randomized clinical trial to assess the efficacy and safety of favipiravir in patients with COVID-19 disease with pneumonia.

Methods: A randomized, double blind, placebo-controlled clinical trial of favipiravir in patients with COVID-19 pneumonia was conducted in three Spanish sites. Randomization 1:1 to favipiravir or placebo (in both groups added to the Standard of Care) was performed to treat the patients with COVID-19 pneumonia.

View Article and Find Full Text PDF
Article Synopsis
  • There are a lot of people in hospitals who say they're allergic to penicillin, and this can make their treatment harder!
  • A study compared patients who had a penicillin allergy and were treated with a special method called desensitization to those treated with other antibiotics!
  • The results showed that even though the desensitized patients had more health problems, they didn't have worse outcomes than those who used alternative treatments, suggesting desensitization could be a helpful option!
View Article and Find Full Text PDF

The interplay between antibiotic resistance and bacterial fitness/virulence has attracted the interest of researchers for decades because of its therapeutic implications, since it is classically assumed that resistance usually entails certain biological costs. Reviews on this topic revise the published data from a general point of view, including studies based on clinical strains or -evolved mutants in which the resistance phenotype is seen as a final outcome, i.e.

View Article and Find Full Text PDF

Tools for the evaluation of COVID-19 severity would help clinicians with triage decisions, especially the decision whether to admit to ICU. The aim of this study was to evaluate SeptiCyte RAPID, a host immune response assay (Immunexpress, Seattle USA) as a triaging tool for COVID-19 patients requiring hospitalization and potentially ICU care. SeptiCyte RAPID employs a host gene expression signature consisting of the ratio of expression levels of two immune related mRNAs, PLA2G7 and PLAC8, measured from whole blood samples.

View Article and Find Full Text PDF

The objective was to compare clinical characteristics, outcomes, and economic differences in complicated urinary tract infections (cUTI) caused by extensively drug-resistant Pseudomonas aeruginosa (XDR P. aeruginosa) and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-K. pneumoniae).

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how to help patients with allergies to antibiotics, which can make treatments less effective.
  • Researchers tested a method called antibiotic desensitization and found it generally worked well and safely for these patients.
  • In their review, they saw that almost all desensitization attempts were successful and no patients died from this procedure, suggesting it’s a good option for those allergic to penicillin.
View Article and Find Full Text PDF

Introduction: Community-acquired bacterial pneumonia (CABP) is the most common infectious cause of hospital admission in adults, and poses a significant clinical and economic burden. At the same time, antimicrobial resistance is increasing worldwide with only a few new antibiotics developed in recent years. Delafloxacin is an anionic fluoroquinolone available in intravenous and oral formulations and with a broad spectrum of activity targeting Gram-positives, including methicillin-resistant (MRSA), gram-negative organisms, and atypical and anaerobic organisms.

View Article and Find Full Text PDF
Article Synopsis
  • A study compared clinical characteristics and outcomes of patients with COVID-19 and seasonal influenza who needed supplemental oxygen, focusing on factors like age, comorbidities, and mortality rates.
  • COVID-19 patients were generally younger but had more severe symptoms, including higher pneumonia rates and worse progression, leading to a significantly higher 30-day mortality rate of 15% compared to 5% for influenza patients.
  • Additionally, COVID-19 patients experienced longer hospital stays and higher costs related to critical care and treatments compared to those with seasonal influenza.
View Article and Find Full Text PDF

Introduction: Extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) infections are difficult to treat. We aimed to compare aminoglycosides or polymyxin monotherapy versus other antibiotic regimens (carbapenems, aztreonam, ceftazidime, cefepime, ceftolozane-tazobactam, or ceftazidime-avibactam) in complicated urinary tract infections (cUTI) caused by XDR-PA.

Methods: Study performed at a tertiary-care hospital from 2010 to 2019.

View Article and Find Full Text PDF

Background: High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in patients with community-onset UTI in emergency departments (EDs).

Methods: A retrospective study was performed of all ED patients with positive urine cultures for or in a Spanish tertiary-care hospital.

View Article and Find Full Text PDF